Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience

Sorafenib is a multi-targeted tyrosine kinase receptor inhibitor used to treat patients with advanced gastrointestinal stromal tumors (GISTs). The present study evaluated the efficacy and tolerability of sorafenib therapy for patients with GISTs. Between January 2001 and November 2012, 25 patients,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: KEFELI, UMUT, BENEKLI, MUSTAFA, SEVINC, ALPER, YILDIZ, RAMAZAN, KAPLAN, MUHAMMED ALI, CILTAS, AYDIN, BALAKAN, OZAN, ISIKDOGAN, ABDURRAHMAN, COSKUN, UGUR, DANE, FAYSAL, HARPUTLUOGLU, HAKAN, KARACA, HALIT, YAZILITAS, DOGAN, DURNALI, AYSE, KAYA, ALI OSMAN, DEMIRCI, UMUT, GUMUS, MAHMUT, BUYUKBERBER, SULEYMAN
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2013
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3789037/
https://ncbi.nlm.nih.gov/pubmed/24137379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2013.1408
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak